Literature DB >> 21723306

Protection against 2-chloroethyl ethyl sulfide (CEES)-induced cytotoxicity in human keratinocytes by an inducer of the glutathione detoxification pathway.

Erika L Abel1, Jennifer D Bubel, Melissa S Simper, Leslie Powell, S Alex McClellan, Michael Andreeff, Michael C MacLeod, John DiGiovanni.   

Abstract

Sulfur mustard (SM or mustard gas) was first used as a chemical warfare agent almost 100years ago. Due to its toxic effects on the eyes, lungs, and skin, and the relative ease with which it may be synthesized, mustard gas remains a potential chemical threat to the present day. SM exposed skin develops fluid filled bullae resulting from potent cytotoxicity of cells lining the basement membrane of the epidermis. Currently, there are no antidotes for SM exposure; therefore, chemopreventive measures for first responders following an SM attack are needed. Glutathione (GSH) is known to have a protective effect against SM toxicity, and detoxification of SM is believed to occur, in part, via GSH conjugation. Therefore, we screened 6 potential chemopreventive agents for ability to induce GSH synthesis and protect cultured human keratinocytes against the SM analog, 2-chloroethyl ethyl sulfide (CEES). Using NCTC2544 human keratinocytes, we found that both sulforaphane and methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate (CDDO-Me) stimulated nuclear localization of Nrf2 and induced expression of the GSH synthesis gene, GCLM. Additionally, we found that treatment with CDDO-Me elevated reduced GSH content of NCTC2544 cells and preserved their viability by ~3-fold following exposure to CEES. Our data also suggested that CDDO-Me may act additively with 2,6-dithiopurine (DTP), a nucleophilic scavenging agent, to increase the viability of keratinocytes exposed to CEES. These results suggest that CDDO-Me is a promising chemopreventive agent for SM toxicity in the skin.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723306     DOI: 10.1016/j.taap.2011.06.012

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Synthesis and characterization of DNA minor groove binding alkylating agents.

Authors:  Prema Iyer; Ajay Srinivasan; Sreelekha K Singh; Gerard P Mascara; Sevara Zayitova; Brian Sidone; Elise Fouquerel; David Svilar; Robert W Sobol; Michael S Bobola; John R Silber; Barry Gold
Journal:  Chem Res Toxicol       Date:  2012-12-26       Impact factor: 3.739

Review 2.  Antioxidants as potential medical countermeasures for chemical warfare agents and toxic industrial chemicals.

Authors:  Cameron S McElroy; Brian J Day
Journal:  Biochem Pharmacol       Date:  2015-10-22       Impact factor: 5.858

Review 3.  Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

Authors:  Ajay Srinivasan; Barry Gold
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

4.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

Review 5.  Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.

Authors:  Muthu K Shanmugam; Xiaoyun Dai; Alan Prem Kumar; Benny K H Tan; Gautam Sethi; Anupam Bishayee
Journal:  Cancer Lett       Date:  2014-01-30       Impact factor: 8.679

Review 6.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

7.  Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog.

Authors:  E L Abel; S Boulware; T Fields; E McIvor; K L Powell; J DiGiovanni; K M Vasquez; M C MacLeod
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-30       Impact factor: 4.219

Review 8.  TrxR1 as a potent regulator of the Nrf2-Keap1 response system.

Authors:  Marcus Cebula; Edward E Schmidt; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

9.  Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).

Authors:  Ronald G Udasin; Xia Wen; Kristin M Bircsak; Lauren M Aleksunes; Michael P Shakarjian; Ah-Ng Tony Kong; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2015-10-09       Impact factor: 4.849

10.  Role of Nrf2 and Autophagy in Acute Lung Injury.

Authors:  Montserrat Rojo de la Vega; Matthew Dodson; Christine Gross; Heidi M Mansour; R Clark Lantz; Eli Chapman; Ting Wang; Stephen M Black; Joe G N Garcia; Donna D Zhang
Journal:  Curr Pharmacol Rep       Date:  2016-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.